6 results
PRE 14A
LBPH
Longboard Pharmaceuticals, Inc.
28 Mar 24
Preliminary proxy
4:36pm
of their Nomination and Compensation Committee, the Sustainable Development Committee and the Audit Committee. Dr. Le Goff received a Pharm. D. from the University … are committed to building a sustainable and successful world-class neurology team to deliver transformative medicines to patients globally, and to deliver
DEF 14A
LBPH
Longboard Pharmaceuticals, Inc.
13 Apr 22
Definitive proxy
4:15pm
, from October 2014 until October 2020, where she served as a member of the Nomination and Compensation Committee, the Sustainable Development Committee … a sustainable and successful world-class neurology team to deliver transformative medicines to patients globally, and to deliver value to our key stakeholders
424B4
LBPH
Longboard Pharmaceuticals, Inc.
12 Mar 21
Prospectus supplement with pricing info
5:02pm
and Compensation Committee, the Sustainable Development Committee and the Audit Committee. Dr. Le Goff received a Pharm. D. from the University Paris V and an M.B.A
S-1/A
wsa32
8 Mar 21
IPO registration (amended)
6:13am
- Prev
- 1
- Next